Nothing Special   »   [go: up one dir, main page]

Case and Technique Reviews: Calcified Lesions, Plaque Modification, and Atherectomy

Download as pdf or txt
Download as pdf or txt
You are on page 1of 62

Case and Technique Reviews:

Calcified Lesions, Plaque


Modification, and Atherectomy
Ajay J. Kirtane, MD, SM
Center for Interventional Vascular Therapy
Columbia University Medical Center /
New York Presbyterian Hospital

@ajaykirtane
Disclosure Statement of Financial Interest

• Ajay J. Kirtane
 Institutional grants to Columbia University
and/or Cardiovascular Research Foundation
from Medtronic, Boston Scientific, Abbott
Vascular, Abiomed, CSI, CathWorks,
Siemens, Philips, ReCor Medical
The Underexpanded Stent: This is a Real Problem

7F EBU 3.5 IVUS – Wouldn’t cross


2.0 x 15 balloon: would not cross 1.25 x 6 followed by 1.5 mm balloon
NC Quantum 3.0 x 15 @ 30 (x4 times) NC Euphora 3.0 x 15 @ 30 (x2 times)
How/Why
Did This Happen?
Calcification on Angiography

• Moderate:
Seen only during
cardiac motion,
usually one side
of vessel

• Severe:
Seen on still frame,
usually both sides
of vessel
IVUS Detection of Calcium

Because IVUS does not penetrate into calcium. . .


1) It cannot measure thickness or mass, only arc and length
2) We assume that superficial calcium is thicker than deep calcium
Potkin et al. Circulation 2001;81:1575-85
Lee et al. Am J Cardiol 2011;108:1547-51
Unlike IVUS, OCT penetrates calcium and is able to
assess calcium thickness and area/volume as well as
arc. However, there is little data assessing the impact
of OCT-measured calcium (arc, thickness, etc) on
stent expansion.

Stent expansion Calcium Arc <90° Calcium Arc >90°


ANOVA p=0.02
Calcium Area <1.58 mm2 77.9%* 73.6%
*p=0.01
Calcium Area >1.58 mm2 71.5% 69.3%*

Yabushita et al. Circulation 2002;106:1640-5


Yamada et al. TCT2013
Frequency of “heavy” calcification in the
SYNTAX trial: Randomized + Registry
N=2,636 pts with LM or 3VD
PCI (n=1,095) CABG (n=1,541)

50.6% 54.2%

Farooq et al. J Am Coll Cardiol 2013;61:282–94


Implications of coronary calcification
• Coronary calcification results in:
 Impaired stent delivery, decreased
stent expansion, increased
malapposition and stent asymmetry
 Increased procedural complications
(edge dissections and perforations)
 Increased rates of stent thrombosis
and restenosis
MACE Study
1- year Events Stratified by Calcium Severity
30.0
None/mild Moderate Severe
p<0.001
25.0 24.2

20.0
Event Rate (%)

p<0.001
15.0
13.2
p=0.003
10.3
10.0 8.5

p=0.489 5.4
5.0 4.1 4.3
2.7
1.6 1.5 1.6
0
0.0
Cardiac Death MI TVR MACE

Sharma et al. Catheter Cardiovasc Interv.;1-8 https://doi.org/10.1002/ccd.28099


Lesion Preparation =
Plaque modification + lumen expansion
• Facilitates procedural success when
treating calcified/complex lesions
 enables lesion access for balloons and
especially stents
• Plaque modification: changing lesion
compliance
 minimizes vessel “trauma” (severe
dissections)
 creates a larger MLD
Why is Appropriate Lesion Preparation for
Coronary Calcification Important?
Lesion calcification:
• May impair stent delivery or expansion
• May abrade polymers off DES

Stentablation
Kobayashi et al.
CCI
2001;52:208-11
Calcium Volume Index (CVI) Scoring System

Fujino et al, Eurointervention 2018


Calcium Fracture and Relation to Outcomes
61 pts with heavily calcified lesions studied serially with OCT
Fracture was seen in 48% (more frequently with CB or atherectomy)

Fracture was associated with greater MSA and less restenosis/ID-TLR

Kubo et al, JACC CV Imaging 2015


Treatment of Calcified Lesions: Options
NC balloons Cutting balloon Angiosculpt

Laser Rotational atherectomy Orbital atherectomy


Strategy for Approaching Calcified Lesions
Angiographic
Calcification?

Mild Moderate Severe

Calcification on Imaging?
- +

Mild, Mod/severe,
Adventitial Luminal

Non-atherectomy Atherectomy
strategy Strategy
Strategic Failure

Adapted from Tomey et al, JACC CV Intv 2014


Rotablator Rotational Atherectomy System

guide wire
FDA approved May 1993

diamond coated burr


1.25 mm - 2.5 mm
drive shaft (0.25 mm increments)

1.5mm 1.75mm
1.25 mm 2.0mm
sheath
4.3 french O.D.
DIAMONDBACK 360: Coronary
Orbital Atherectomy System
Device Features
•Simple device setup
On-handle speed control
•Microsecond feedback •Low (80K) and High Speed (120K)
to changes in loading
•135cm usable length
Power on/off switch
•8 cm axial travel
Electric motor
powered
Eccentric handle
diamond coated
crown

6Fr Guide 0.012” Viper Wire


Compatible

ViperSlide® Lubricant
•ViperSlide reduces friction during
Saline Infusion Pump operation
•Mounts directly on to an IV pole •20ml ViperSlide per liter of saline
•Provides power
•Delivers fluid
•Includes saline sensor
Coronary Intravascular Lithotripsy (IVL)

Ali Z et al, JACC CV Imaging 2017


Case Presentation
• 73F with PAF on anticoagulation with unstable
angina (some atypical features) that
“stabilized” with medical therapy
• Nuclear stress test: anteroseptal ischemia
• No further recurrence of rest chest pain
though has CCS III angina despite beta-
blocker and CCB
Left Coronary System
How Would You Treat?

• Atherectomy
• Specialty Balloon
• NC Balloon
• Imaging

Randomized in ECLIPSE
ECLIPSE
Evaluation of Treatment Strategies for Severe CaLcifIc Coronary
Arteries: Orbital Atherectomy vs. Conventional Angioplasty Prior
to Implantation of Drug Eluting StEnts

~2000 pts with severely calcified lesions; ~60 US sites


Randomize
Orbital Atherectomy Strategy 1:1 Conventional Angioplasty Strategy

(1.25 mm Crown followed by non- (conventional and/or specialty


compliant balloon optimization) balloons per operator discretion)

2nd generation DES implantation 2nd generation DES implantation


and optimization and optimization

1° endpoints: 1) Post-PCI in-stent MSA (N~400 in imaging study)


2) 1-year TVF (all patients)
2° endpoint: Procedural Success (stent deployed w/RS<20% & no maj complications)
Principal investigators: Ajay J. Kirtane, Philippe Généreux; Study chairman: Gregg W. Stone
Sponsor: Cardiovascular Systems Inc.
Final Angiogram
7F EBU 3.5 GC
Sion Blue GW
(Workhorse GW
would not cross)
Turnpike LP advanced
(Corsair would not
cross)
WHAT
NEXT?
Time for…
Sion Blue GW
removed
Atherectomy wire
advanced through
microcatheter
After atherectomy,
wire exchanged for
a Wiggle Wire
Diagonal protected

NC 3.0 x 15 mm
@ 16 atm
NC 3.5 x 15 @ 14 atm
IVUS
IVUS (post Atherectomy/POBA)
Unable to advance
stent to lesion
WHAT
NEXT?
6F Guide Extension
Final (after postdilation/IVUS)
Case Presentation
• 69 y.o. male with HTN, HLD, • Vitals: T 36.4, HR 75, BP: 139/82,
CVA (25 years ago, residual R RR 18, SpO2 98% on RA.
hemiparesis) • PE: No JVD, RRR, nml S1/S2, no
murmur
• CAD (with MI in the past) • CTA B/L
• Worsening exertional angina, • +2 pulses b/l, no edema
no rest symptoms Labs:
WBC: 9.43 / Hb: 15.5 (MCV: 91.1) /
• Medications: Hct: 44.9 / Plt: 203

 Aspirin, Clopidogrel, Atorvastatin 144 | 101 | 12


--------------------< 113
20, Furosemide 20 mg, Metoprolol 4.3 | 28 | 0.88
succinate 100 mg, Baclofen,
pro-BNP: 223, Coags: normal
Phenytoin, Ranitidine
Troponin mildly positive and stable
Case Presentation

• Echocardiogram:
 EF 20-25%
 Anterior/
anteroseptal/apical
akinesis (without
thrombus)
 Remaining walls
variably hypokinetic
Diagnostic Catheterization
RHC:
RA 17/10 (10)
RV 31/17
PA 31/20 (25)
PW 24/20 (19)

PA sat 66%
AO sat 94%

CO 4.6
CI 2.3

AoP: 89/58/72
Diagnostic Catheterization
Diagnostic Catheterization
What Next?
What Next?
Viability Study: no significant viability in the
LAD distribution. All other walls are viable.
Access and Setup
6-7F slender Ao 105/77/88
RRA
RA 13/9 (8)
Ultrasound- RV 33/13
guided 5F RFA PA 33/16 (22)
PW 12/9 (8)
(swapped for
14F Impella AO sat 96%
sheath) PA sat 63%

7F RFV CO 4.27
CI 2.18
Access and Setup

JL3.5, angled glide wire, Impella CP


Amplatz SS to advance guide 7F AL 0.75 SH guide
PCI: Atherectomy
PCI: Post-Atherectomy
PCI: Thrombectomy
PCI: 3.0 mm NC Predil, 4.5 mm DES
Final result
Finishing Up / Impella Explant

Hemodynamics: Long multipurpose


Ao 101/74/84 catheter placed in
right iliac artery
RHC: via RRA
PA 44/13/30
PCWP: mean 23 Perclose sutures
tied
PA sat 62%
Light manual
CO 3.71 pressure for track
CI 1.89 ooze
Conclusions
• Coronary calcium is becoming more and more prevalent in
the modern-day cath lab / CHIP era
• Aging population
• Comorbidities
• “Downstream” presentations

• Calcified lesions are among the highest-risk lesions we treat


• Short-term pain/suffering + risk
• Longer-term outcomes
Conclusions
• Imaging is a MUST
• Diagnosis of calcium
• Treatment algorithms (based upon length, arc, thickness)
• After initial lesion preparation and prior to stent implantation
• Stent optimization

• The field of adjunctive therapies for calcific lesions is


heating up with more and more data emerging soon…

You might also like